Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04620772
Recruitment Status : Not yet recruiting
First Posted : November 9, 2020
Last Update Posted : December 30, 2020
Sponsor:
Information provided by (Responsible Party):
Arunmozhimaran Elavarasi, All India Institute of Medical Sciences, New Delhi